BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32419327)

  • 1. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
    Schlegel N; Boerner K; Waschke J
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoglein2 Regulates Claudin2 Expression by Sequestering PI-3-Kinase in Intestinal Epithelial Cells.
    Burkard N; Meir M; Kannapin F; Otto C; Petzke M; Germer CT; Waschke J; Schlegel N
    Front Immunol; 2021; 12():756321. PubMed ID: 34659262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease.
    Meir M; Burkard N; Ungewiß H; Diefenbacher M; Flemming S; Kannapin F; Germer CT; Schweinlin M; Metzger M; Waschke J; Schlegel N
    J Clin Invest; 2019 Jun; 129(7):2824-2840. PubMed ID: 31205031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Talk about micromanaging! Role of microRNAs in intestinal barrier function.
    Al-Sadi R; Engers J; Abdulqadir R
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G170-G174. PubMed ID: 32658620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dsg2 via Src-mediated transactivation shapes EGFR signaling towards cell adhesion.
    Ungewiß H; Rötzer V; Meir M; Fey C; Diefenbacher M; Schlegel N; Waschke J
    Cell Mol Life Sci; 2018 Nov; 75(22):4251-4268. PubMed ID: 29980799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.
    Cheng Y; Hall TR; Xu X; Yung I; Souza D; Zheng J; Schiele F; Hoffmann M; Mbow ML; Garnett JP; Li J
    EBioMedicine; 2022 Jan; 75():103758. PubMed ID: 34933179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of intestinal epithelial intercellular adhesion and barrier function by desmosomal cadherin desmocollin-2.
    Raya-Sandino A; Luissint AC; Kusters DHM; Narayanan V; Flemming S; Garcia-Hernandez V; Godsel LM; Green KJ; Hagen SJ; Conway DE; Parkos CA; Nusrat A
    Mol Biol Cell; 2021 Apr; 32(8):753-768. PubMed ID: 33596089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoglein 2 can undergo Ca
    Fuchs M; Kugelmann D; Schlegel N; Vielmuth F; Waschke J
    Biophys J; 2022 Apr; 121(7):1322-1335. PubMed ID: 35183520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of nasal polyposis: the role of desmosomal junctions.
    Zuckerman JD; Lee WY; DelGaudio JM; Moore CE; Nava P; Nusrat A; Parkos CA
    Am J Rhinol; 2008; 22(6):589-97. PubMed ID: 19178795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium.
    Nava P; Laukoetter MG; Hopkins AM; Laur O; Gerner-Smidt K; Green KJ; Parkos CA; Nusrat A
    Mol Biol Cell; 2007 Nov; 18(11):4565-78. PubMed ID: 17804817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides.
    Muntjewerff EM; Tang K; Lutter L; Christoffersson G; Nicolasen MJT; Gao H; Katkar GD; Das S; Ter Beest M; Ying W; Ghosh P; El Aidy S; Oldenburg B; van den Bogaart G; Mahata SK
    Acta Physiol (Oxf); 2021 Jun; 232(2):e13655. PubMed ID: 33783968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoplakin Maintains Transcellular Keratin Scaffolding and Protects From Intestinal Injury.
    Gross A; Zhou B; Bewersdorf L; Schwarz N; Schacht GM; Boor P; Hoeft K; Hoffmann B; Fuchs E; Kramann R; Merkel R; Leube RE; Strnad P
    Cell Mol Gastroenterol Hepatol; 2022; 13(4):1181-1200. PubMed ID: 34929421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cldn-7 deficiency promotes experimental colitis and associated carcinogenesis by regulating intestinal epithelial integrity.
    Wang K; Ding Y; Xu C; Hao M; Li H; Ding L
    Oncoimmunology; 2021 May; 10(1):1923910. PubMed ID: 34026335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-9-induced increase in intestinal epithelial tight permeability is mediated by p38 kinase signaling pathway activation of MLCK gene.
    Al-Sadi R; Youssef M; Rawat M; Guo S; Dokladny K; Haque M; Watterson MD; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2019 Feb; 316(2):G278-G290. PubMed ID: 30543452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation.
    Laudisi F; Stolfi C; Bevivino G; Maresca C; Franzè E; Troncone E; Lolli E; Marafini I; Pietrucci D; Teofani A; Di Grazia A; Di Fusco D; Colantoni A; Ortenzi A; Desideri A; Monteleone I; Monteleone G
    J Crohns Colitis; 2022 Feb; 16(2):301-311. PubMed ID: 34374415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk.
    Bhat AA; Uppada S; Achkar IW; Hashem S; Yadav SK; Shanmugakonar M; Al-Naemi HA; Haris M; Uddin S
    Front Physiol; 2018; 9():1942. PubMed ID: 30728783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wheat gluten intake increases the severity of experimental colitis and bacterial translocation by weakening of the proteins of the junctional complex.
    Menta PLR; Andrade MER; Leocádio PCL; Fraga JR; Dias MTS; Cara DC; Cardoso VN; Borges LF; Capettini LSA; Aguilar EC; Alvarez-Leite JI
    Br J Nutr; 2019 Feb; 121(4):361-373. PubMed ID: 30554574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
    Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
    Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus-binding protein FKBP8 directs myosin light chain kinase-dependent barrier regulation and is a potential therapeutic target in Crohn's disease.
    Zuo L; Kuo WT; Cao F; Chanez-Paredes SD; Zeve D; Mannam P; Jean-François L; Day A; Vallen Graham W; Sweat YY; Shashikanth N; Breault DT; Turner JR
    Gut; 2023 May; 72(5):870-881. PubMed ID: 35537812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoskeletal Organization and Cell Polarity in the Pathogenesis of Crohn's Disease.
    Guo C; Shen J
    Clin Rev Allergy Immunol; 2021 Apr; 60(2):164-174. PubMed ID: 32474815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.